The company's financial position appears strained, with goodwill now comprising 72.6% of total assets and retained earnings declining to -$49.3M as of 2026Q1.
| Total Current Assets | 18.89M | 13.15M | 1.45M | 5.65M | 8.02M | 11.8M | 8.03M | 5.29M |
| Cash & Short-Term Investments | 4.32M | 7.63M | 20K | 1.23M | 1.34M | 1.77M | 1.4M | 974.83K |
| Cash Only | 4.32M | 7.63M | 20K | 1.23M | 1.34M | 1.77M | 1.4M | 974.83K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 9.82M | 2.07M | 1.11M | 3.6M | 5.87M | 9.67M | 6.4M | 4.17M |
| Days Sales Outstanding | 106.14 | 54.39 | 34.64 | 39.52 | 46.65 | 100.09 | 74.5 | 52.97 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.24M | 3.19M | 322K | 824K | 816K | 362K | 228.85K | 146.3K |
| Total Non-Current Assets | 61.27M | 9.59M | 509K | 1.21M | 5.24M | 12.81M | 3.08M | 2.96M |
| Property, Plant & Equipment | 2.5M | 5K | 12K | 44K | 80K | 246K | 15.79K | 41.65K |
| Fixed Asset Turnover | 31.95x | 2778.20x | 974.67x | 754.61x | 573.58x | 143.37x | 1985.24x | 690.02x |
| Goodwill | 0 | 2.95M | 0 | 0 | 0 | 1.29M | 0 | 0 |
| Intangible Assets | 58.16M | 2.81M | 0 | 857K | 4.08M | 10.46M | 2.62M | 2.92M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 1.07M | 0 | 445K | 0 |
| Other Non-Current Assets | 204K | 3.83M | 497K | 304K | 0 | 816K | 0 | 0 |
| Total Assets | 80.16M | 22.74M | 1.96M | 6.86M | 13.26M | 24.61M | 11.11M | 8.25M |
| Asset Turnover | 0.61x | 0.61x | 5.96x | 4.84x | 3.46x | 1.43x | 2.82x | 3.48x |
| Asset Growth % | 1971.91% | 1059.41% | -71.41% | -48.29% | -46.12% | 121.59% | 34.6% | - |
| Total Current Liabilities | 20.99M | 12.79M | 7.08M | 8.15M | 6.6M | 6.25M | 6.78M | 6.2M |
| Accounts Payable | 3.29M | 744K | 2.54M | 1.95M | 1.48M | 1.87M | 4.35M | 5.1M |
| Days Payables Outstanding | 40.04 | 22.63 | 105.24 | 26.98 | 15.63 | 27.62 | 67.4 | 78.66 |
| Short-Term Debt | 9.54M | 10.74M | 2.65M | 3.79M | 2.69M | 3.28M | 754.4K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 297.77K | 749.03K |
| Other Current Liabilities | 8.16M | 0 | 1.89M | 2.41M | 2.43M | 924K | 1.38M | 349.14K |
| Current Ratio | 0.90x | 1.03x | 0.21x | 0.69x | 1.22x | 1.89x | 1.18x | 0.85x |
| Quick Ratio | 0.90x | 1.03x | 0.21x | 0.69x | 1.22x | 1.89x | 1.18x | 0.85x |
| Cash Conversion Cycle | 66.11 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 6.47M | 0 | 0 | 97K | 625K | 2.23M | 0 | 79.04K |
| Long-Term Debt | 629K | 0 | 0 | 97K | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 700K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.14M | 0 | 0 | 0 | 625K | 2.23M | 0 | 79.04K |
| Total Liabilities | 27.46M | 12.79M | 7.08M | 8.25M | 7.22M | 8.48M | 6.78M | 6.28M |
| Total Debt | 10.87M | 10.74M | 2.65M | 3.88M | 2.69M | 3.45M | 754.4K | 0 |
| Net Debt | 6.56M | 3.11M | 2.63M | 2.65M | 1.34M | 1.68M | -648.3K | -974.83K |
| Debt / Equity | 0.21x | 1.08x | - | - | 0.44x | 0.21x | 0.17x | - |
| Debt / EBITDA | -1.04x | - | - | - | - | - | 0.38x | - |
| Net Debt / EBITDA | -0.62x | - | - | - | - | - | -0.33x | -0.40x |
| Interest Coverage | -47.42x | -17.26x | -3.91x | -7.94x | -64.34x | -9.45x | 14.96x | 31.75x |
| Total Equity | 52.7M | 9.94M | -5.11M | -1.39M | 6.04M | 16.14M | 4.33M | 1.97M |
| Equity Growth % | 3069.16% | 294.45% | -267.65% | -123.03% | -62.57% | 272.77% | 119.17% | - |
| Book Value per Share | 85132.47 | 16064.62 | -14474.98 | -4972.68 | 24398.07 | 81914.51 | 18379.27 | 8386.00 |
| Total Shareholders' Equity | 52.76M | 9.98M | -5.11M | -1.39M | 6.04M | 16.14M | 4.33M | 1.97M |
| Common Stock | 11K | 11K | 0 | 0 | 0 | 0 | 279 | 279 |
| Retained Earnings | -49.34M | -43M | -33.57M | -27.6M | -18.92M | -2.66M | 3.29M | 932.63K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -61K | -37K | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and capital exhaustion
According to recent financial filings, HCTI's total assets expanded to $80.2M in 2026Q1 from $22.7M in 2025Q4, yet this growth is heavily skewed by a $58.2M goodwill balance, suggesting that the underlying quality of the balance sheet remains highly sensitive to potential future impairment charges.
The rapid expansion of the asset base appears driven by inorganic activity rather than organic capital accumulation, which warrants caution regarding the long-term sustainability of the firm's financial position. Investors should monitor whether these intangible assets provide actual economic value or if they represent a temporary accounting inflation that masks the underlying operational weakness.
As reported in quarterly statements, the current ratio declined to 0.90 in 2026Q1, indicating that the company's ability to cover short-term obligations is increasingly reliant on external financing rather than internal cash generation, especially given the cash position of only $4.3M against significant operational burn.
The compression of the current ratio below parity suggests that the firm is operating with a thin margin of safety, leaving it vulnerable to any unexpected disruptions in its service-based revenue streams. This liquidity profile appears to necessitate frequent capital raises, which may continue to dilute existing shareholders if profitability remains elusive.
Based on the 2026Q1 balance sheet, goodwill accounts for approximately 72.6% of total assets, a significant shift from previous periods where tangible assets were more prominent, indicating that the company's valuation is increasingly tied to subjective assessments of acquired business value rather than physical infrastructure.
The heavy reliance on goodwill as a primary asset component suggests that the firm's book value may be overstated if the acquired entities fail to meet performance expectations. This asset mix implies a high degree of risk, as any failure to integrate these acquisitions effectively could lead to substantial write-downs that would further erode the equity base.
As evidenced by the historical financial data, retained earnings have plummeted to -$49.3M as of 2026Q1, reflecting a persistent inability to generate positive net income, which continues to weigh heavily on the company's total equity position despite recent capital injections.
The consistent accumulation of negative retained earnings suggests that the business model has yet to achieve the scale required for self-sustaining operations. This trend indicates that the equity base is being maintained primarily through external financing rather than organic growth, which may limit the company's strategic flexibility in the future.
Quick answers to the most common questions about buying HCTI stock.
As of 2025, Healthcare Triangle, Inc. (HCTI) had total assets of $22.7M including $13.2M in current assets.
Healthcare Triangle, Inc. (HCTI) carries total debt of $10.7M, offset by $7.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Healthcare Triangle, Inc. (HCTI) has total shareholders' equity (book value) of $10.0M ($16064.62 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Healthcare Triangle, Inc. (HCTI) reported a current ratio of 1.03x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.